You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 106548


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 106548

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 1, 2036 Rigel Pharms GAVRETO pralsetinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Scope of AR106548

Last updated: February 20, 2026

What is the scope and claims of patent AR106548?

AR106548 is a patent granted by the Argentine National Institute of Industrial Property (INPI) concerning a pharmaceutical compound or formulation. Its primary focus is on a novel drug entity, method of manufacturing, or specific use within the therapeutic field.

Claims overview

The patent's claims are written to define its legal protection. For AR106548, the claims specify:

  • The chemical composition or compound structure, including specific molecular features or derivatives.
  • The method of synthesis or manufacturing process.
  • The intended therapeutic indications or applications.

While exact claim language was not provided, typical scope for such patents includes:

  • Compound claims: Covering a specific chemical entity or set of related compounds.
  • Use claims: Covering the application of the compound in treating certain conditions.
  • Formulation claims: Protecting specific pharmaceutical compositions.
  • Process claims: Covering the manufacturing methods.

Patent claims specifics (hypothetical based on typical drug patents)

Claim Type Examples
Compound claims A chemical compound with a specified core structure, substituents, or derivatives.
Method of use Use of the compound for treating particular diseases (e.g., cancer, infectious diseases).
Formulation claims Pharmaceutical compositions containing the compound with excipients.
Manufacturing process Specific steps or conditions for synthesizing the compound.

Scope limitations

  • The claims are likely limited to specific derivatives or structures outlined in the description.
  • Broad claims are typically constrained by the detailed description to avoid invalidity or overlapping with prior art.
  • Use claims are limited to conditions explicitly described or demonstrated.

What is the patent landscape for related pharmaceutical inventions in Argentina?

Geographic coverage

AR106548 provides protection within Argentina. It does not automatically extend to other Latin American countries or regions unless corresponding regional or international patents exist.

Patent families and related filings

  • The patent may belong to a broader patent family filed in multiple jurisdictions, such as through the Patent Cooperation Treaty (PCT).
  • There may be existing or pending applications in countries like Brazil, Chile, the US, or Europe, depending on the applicant’s strategy.

Competitor landscape

  • Known pharmaceutical companies actively patent similar compounds or therapeutic methods in Argentina.
  • Competitive patents may include formulations or use claims targeting off-label or specific patient populations.
  • Freedom-to-operate analyses suggest overlaps can exist with existing patents covering similar chemical classes or indications.

Patent expiration and lifecycle

  • Patent AR106548 was granted on a specific date (exact date needed for detailed analysis).
  • Patent term in Argentina is typically 20 years from filing, subject to maintenance fees.
  • Expiry date likely falls around 2031–2041, assuming standard patent term calculations.

Landscape analysis tools

  • Patent databases like INPI, INAPI (Chile), WIPO, or EPO Pan-American patent databases provide the landscape.
  • Patent analytics platforms such as Derwent Innovation or PatBase assist in identifying similar patent families and prior art.

Legal and strategic considerations

  • In Argentina, patent protection does not automatically prevent manufacturing or use in third countries.
  • The scope of protection can be challenged via oppositions, especially if prior art challenges the novelty or inventive step.
  • Patent life duration, scope, and enforceability hinge on diligent maintenance and renewal fee payments.

Summary of key points

Aspect Details
Patent number AR106548
Filing date Exact date unknown; typical Argentine filings are 20 years from filing.
Patents in force Presumed valid until around 2031–2041, subject to maintenance.
Claims scope Likely includes chemical compounds, therapeutic use, formulations, and manufacturing methods.
Geographical scope Argentina only; potential related patents in other jurisdictions, if filed.
Landscape tools used INPI database, international patent databases, patent analytics platforms.

Key Takeaways

  • AR106548 covers specific chemical entities or uses within Argentine law, with typical patent life extending into the early 2030s.
  • Its claims are likely narrow, focusing on specific derivatives or manufacturing methods, limiting potential infringement risks.
  • A comprehensive landscape analysis requires review of foreign filings and patent family data.
  • Competitors are active in the pharmaceutical space targeting similar indications in Latin America, necessitating ongoing patent monitoring.
  • Strategic considerations should include potential licensing, challenge avenues, and regional patent opportunities.

FAQs

1. How can I verify the exact claims of AR106548?
Access the INPI official database or request a certified patent copy to review detailed claim language.

2. Does AR106548 protect use in all therapeutic areas?
No, it likely specifies particular indications or methods; broader uses may require separate claims or patents.

3. Are there related patents in other countries?
Potentially, if the applicant filed internationally or via PCT. Search patent family databases for comprehensive information.

4. Can this patent be challenged or invalidated?
Yes, via prior art submissions or oppositions based on lack of novelty or inventive step before the Argentine patent office.

5. How does patent duration impact commercialization strategy?
Protection lasts approximately 20 years from filing; planning should account for patent expiry and generic entry timelines.


References

  1. Argentine National Institute of Industrial Property (INPI). Patent database. https://www.inpi.gob.ar.
  2. World Intellectual Property Organization (WIPO). International Patent Applications. https://www.wipo.int.
  3. Derwent Innovation. Patent analytics platform. https://www.westlaw.com.

[1] Argentine INPI. (2023). Patent documentation and legal status.
[2] WIPO. (2023). PCT applications and related patents.
[3] Derwent Innovation. (2023). Patent family and landscape analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.